Ecstasy-for-Medicine Advocate Looks for Cash Lifeline
Wall Street Journal
MAPS, a nonprofit, is working on an $85 million private share sale to keep itself afloat until mid-2024, when it hopes to start selling MDMA in the U.S.
https://www.wsj.com/articles/ecstasy-for-medicine-advocate-maps-looks-for-cash-lifeline-326b77fd